Evidence map›Paper›PMID 29135576›Full record

Trial reportAIDS (London, England)2018

Assisted partner notification services are cost-effective for decreasing HIV burden in western Kenya.

Monisha Sharma, Jennifer A Smith, Carey Farquhar, Roger Ying, Peter Cherutich, Matthew Golden, Beatrice Wamuti, David Bukusi, Hans Spiegel, Ruanne V Barnabas

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in AIDS (London, England), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 3 pooled it
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 3 syntheses or guidelines pooled it, 70 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Observational
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Monisha SharmaDepartment of Global Health, University of Washington, Seattle, Washington, USA.
Jennifer A SmithImperial College London, Department of Epidemiology, London, UK.
Carey FarquharDepartment of Global Health, University of Washington, Seattle, Washington, USA.
Roger YingWeill Cornell Medical College, New York, New York, USA.
Peter CherutichMinistry of Health, Nairobi.
Matthew GoldenDepartment of Global Health, University of Washington, Seattle, Washington, USA.
Beatrice WamutiKenyatta National Hospital, Nairobi, Kenya.
David BukusiKenyatta National Hospital, Nairobi, Kenya.
Hans SpiegelKelly Government Solutions, Contractor to the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Ruanne V BarnabasDepartment of Global Health, University of Washington, Seattle, Washington, USA.
University of Washington · USKenyatta National Hospital · KECornell University · USImperial College London · GBMinistry of Health · KE

Funding

VENEREAL DISEASET32AI007140 · NIAID · UNIVERSITY OF WASHINGTON · PI Julia Cook Dombrowski · 1985 to 2026
$19.4M
Assisted Partner Notification to Augment HIV Treatment and Prevention in KenyaR01AI099974 · NIAID · UNIVERSITY OF WASHINGTON · PI FARQUHAR, CAREY · 2012 to 2014
$2.6M
NIAID NIH HHS R01 AI099974NIAID NIH HHS T32 AI007140
6 · The paper itself

Abstract

backgroundAssisted partner services (aPS) or provider notification for sexual partners of persons diagnosed HIV positive can increase HIV testing and linkage in Sub-Saharan Africa and is a high yield strategy to identify HIV-positive persons. However, its cost-effectiveness is not well evaluated.

methodsUsing effectiveness and cost data from an aPS trial in Kenya, we parameterized an individual-based, dynamic HIV transmission model. We estimated costs for both a program scenario and a task-shifting scenario using community health workers to conduct the intervention. We simulated 200 cohorts of 500 000 individuals and projected the health and economic effects of scaling up aPS in a region of western Kenya (formerly Nyanza Province).

findingsOver a 10-year time horizon with universal antiretroviral therapy (ART) initiation, implementing aPS in western Kenya was projected to reach 12.5% of the population and reduce incident HIV infections by 3.7%. In sexual partners receiving aPS, HIV-related deaths were reduced by 13.7%. The incremental cost-effectiveness ratio of aPS was $1094 (US dollars) (90% model variability $823-1619) and $833 (90% model variability $628-1224) per disability-adjusted life year averted under the program and task-shifting scenario, respectively. The incremental cost-effectiveness ratios for both scenarios fall below Kenya's gross domestic product per capita ($1358) and are therefore considered very cost-effective. Results were robust to varying healthcare costs, linkage to care rates, partner concurrency rates, and ART eligibility thresholds (≤350 cells/μl, ≤500 cells/μl, and universal ART).

interpretationAPS is cost-effective for reducing HIV-related morbidity and mortality in western Kenya and similar settings. Task shifting can increase program affordability.

Indexed as

Cost-Benefit AnalysisAdolescentAdultContact TracingDisease Transmission, InfectiousFemaleHIV InfectionsHumansKenyaMaleMiddle AgedModels, StatisticalSurvival AnalysisYoung Adult

Identifiers

PMID29135576
PMCPMC5736414
OpenAlexW2767725315

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.